WHAT IS IN THIS WHAT IS MIRENA Please read this leaflet carefully and keep it, as you may need to read it again. Please contact your doctor if you have any questions about your treatment with MIRENA or if you have any difficulties whilst using MIRENA. WHAT IS MIRENA BEFORE YOU START MIRENA may be used with USING MIRENA caution after specialist consultation or your doctor Not all women should use may consider removal of the MIRENA. All products have system if any of the following benefits and risks. If you are conditions exist or arise for the unsure if MIRENA is suitable first time: for you, discuss this with your INSERTION OF
not very certain. However you should see your doctor immediately if you have any symptoms or signs of clots. MIRENA should not be the first choice of contraception in young women who have not had a baby because of the possibility of more sexual partners and an increased risk of infections. Pelvic infection may impair fertility and increase the risk of ectopic pregnancy. Before you start using Mirena
removed as soon as possible. If you experience excessive pain or bleeding tell your doctor. If you are breastfeeding
your womb (an ectopic pregnancy). The risk of this However this is a serious condition that requires WHILE USING immediate medical attention. The following symptoms could mean that you may have an ectopic pregnancy and you should see your doctor immediately: HOW DOES MIRENA You may need medical treatment if you experience any of the following unwanted effects: SIDE EFFECTS WHAT DOES MIRENA LOOK LIKE OTHER IMPORTANT INFORMATION
expiry date are marked on the carton. The system should not be used after the expiry date.
questions on the use of MIRENA, or are unsure of any of the above information, please see your doctor who will be able to assist you.
Name and Address of the Sponsor
BAYER AUSTRALIA LIMITED ABN 22 000 138 714 875 Pacific Highway PYMBLE NSW 2073 Australia
Australian Registration Number: AUST R 73027 Bayer New Zealand Limited 3 Argus Place
Date of preparation: September 2007
® Registered trademark of the Bayer Group, Germany
Comunicaciones breves / Arch Argent Pediatr 2007; 105(4):333-341 / 339 Comunicaciones breves Varicela y herpes zoster, informe de un caso Dres. Margarita Larralde*, Begoña Gomar* y Horacio Yulitta** Por el buen estado del paciente se decide elSe presenta el caso de un paciente masculino de tres años demanejo ambulatorio con aciclovir a 80 mg/kg/díaedad traído a la consulta
SELECTED HSRN ANNOTATED BIBLIOGRAPHY, 2003-2011 (Updated April 2011). The IMS Health Services Research Network is comprised of academic researchers who are conducting empirically rigorous, policy-relevant studies to improve the quality and cost-effectiveness of health care in the United States. The network includes members from a variety of complementary disciplines including pharmacy, me
OTHER IMPORTANT